3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Active not recruiting
1
Sponsor Class
NETWORK
1
Study Type
Interventional
1
Sponsor
Cancer Type
Genitourinary
1
Conditions
Breast Neoplasms
36
Neoplasms
32
Prostatic Neoplasms
26
Colorectal Neoplasms
25
Lung Neoplasms
21
Carcinoma, Non-Small-Cell Lung
16
Hematologic Neoplasms
13
Neoplasm Metastasis
10
Pancreatic Neoplasms
9
Ovarian Neoplasms
8
Multiple Myeloma
8
Head and Neck Neoplasms
8
Urinary Bladder Neoplasms
7
Triple Negative Breast Neoplasms
7
Squamous Cell Carcinoma of Head and Neck
7
Hematopoietic and Lymphatic System Neoplasm
7
Stomach Neoplasms
6
Carcinoma, Renal Cell
6
Anatomic Stage I Breast Cancer AJCC v8
6
Uterine Cervical Neoplasms
5
Sarcoma
5
Glioma
5
Precursor Cell Lymphoblastic Leukemia-Lymphoma
4
Mouth Neoplasms
4
Motor Activity
4
Melanoma
4
Leukemia, Myeloid, Acute
4
Hematopoietic and Lymphoid System Neoplasm
4
Head and Neck Carcinoma
4
Gastrointestinal Neoplasms
4
Interventions
Radiosurgery
3
Androgen Antagonists
3
Prednisone
2
Docetaxel
2
Abiraterone Acetate
2
fludrocortisone acetate
1
enzalutamide
1
darolutamide
1
apalutamide
1
Standard of Care
1
Radiotherapy, Image-Guided
1
Radiotherapy
1
Pluvicto
1
Midazolam
1
Lutetium-177
1
Lutetium
1
Hydrocortisone
1
Gonadotropin-Releasing Hormone
1
Dexamethasone
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Prostate Cancer Metastatic
×
Standard of Care
×
1 year
×
Clear all
NCT03784755
2026-03-27
PLATON
Canadian Cancer Trials Group
Phase NA
Active not recruiting
409 enrolled